202 related articles for article (PubMed ID: 18209802)
1. Highly shifted LIPOCEST agents based on the encapsulation of neutral polynuclear paramagnetic shift reagents.
Terreno E; Barge A; Beltrami L; Cravotto G; Castelli DD; Fedeli F; Jebasingh B; Aime S
Chem Commun (Camb); 2008 Feb; (5):600-2. PubMed ID: 18209802
[TBL] [Abstract][Full Text] [Related]
2. From spherical to osmotically shrunken paramagnetic liposomes: an improved generation of LIPOCEST MRI agents with highly shifted water protons.
Terreno E; Cabella C; Carrera C; Delli Castelli D; Mazzon R; Rollet S; Stancanello J; Visigalli M; Aime S
Angew Chem Int Ed Engl; 2007; 46(6):966-8. PubMed ID: 17167807
[No Abstract] [Full Text] [Related]
3. Osmotically shrunken LIPOCEST agents: an innovative class of magnetic resonance imaging contrast media based on chemical exchange saturation transfer.
Terreno E; Delli Castelli D; Violante E; Sanders HM; Sommerdijk NA; Aime S
Chemistry; 2009; 15(6):1440-8. PubMed ID: 19115311
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium-doped LipoCEST agents: a potential novel class of dual 1H-MRI probes.
Terreno E; Boffa C; Menchise V; Fedeli F; Carrera C; Castelli DD; Digilio G; Aime S
Chem Commun (Camb); 2011 Apr; 47(16):4667-9. PubMed ID: 21409237
[TBL] [Abstract][Full Text] [Related]
5. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications.
Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E
Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516
[TBL] [Abstract][Full Text] [Related]
6. The thulium complex of 1,4,7,10-tetrakis{[N-(1H-imidazol-2-yl)carbamoyl]methyl}-1,4,7,10-tetraazacyclododecane (dotami) as a ParaCEST contrast agent.
Burdinski D; Lub J; Pikkemaat JA; Langereis S; Grüll H; Ten Hoeve W
Chem Biodivers; 2008 Aug; 5(8):1505-1512. PubMed ID: 18729087
[TBL] [Abstract][Full Text] [Related]
7. Paramagnetic lanthanide complexes as PARACEST agents for medical imaging.
Woods M; Woessner DE; Sherry AD
Chem Soc Rev; 2006 Jun; 35(6):500-11. PubMed ID: 16729144
[TBL] [Abstract][Full Text] [Related]
8. Organocuprates and diamagnetic copper complexes: structures and NMR spectroscopic structure elucidation in solution.
Gschwind RM
Chem Rev; 2008 Aug; 108(8):3029-53. PubMed ID: 18698736
[No Abstract] [Full Text] [Related]
9. 1H and 13C spectral assignments of an oxytocin-DTPA derivative, a ligand for potential receptor-specific MRI contrast agents.
Calabi L; Biondi L; De Miranda M; Ghelli S; Mora C; Paleari L; Rebaudengo C; Umbelli C
Magn Reson Chem; 2005 Aug; 43(8):654-7. PubMed ID: 15986497
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and characterization of novel natural product-Gd(III) MRI contrast agent conjugates.
Efthimiadou EK; Katsarou ME; Fardis M; Zikos C; Pitsinos EN; Kazantzis A; Leondiadis L; Sagnou M; Vourloumis D
Bioorg Med Chem Lett; 2008 Dec; 18(23):6058-61. PubMed ID: 18938075
[TBL] [Abstract][Full Text] [Related]
11. Efficient relaxivity enhancement in dendritic gadolinium complexes: effective motional coupling in medium molecular weight conjugates.
Fulton DA; O'Halloran M; Parker D; Senanayake K; Botta M; Aime S
Chem Commun (Camb); 2005 Jan; (4):474-6. PubMed ID: 15654374
[TBL] [Abstract][Full Text] [Related]
12. Lanthanide complexes based on a 1,7-diaza-12-crown-4 platform containing picolinate pendants: a new structural entry for the design of magnetic resonance imaging contrast agents.
Mato-Iglesias M; Roca-Sabio A; Pálinkás Z; Esteban-Gómez D; Platas-Iglesias C; Tóth E; de Blas A; Rodríguez-Blas T
Inorg Chem; 2008 Sep; 47(17):7840-51. PubMed ID: 18672876
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive thermometry using hyperfine-shifted MR signals from paramagnetic lanthanide complexes.
Hekmatyar SK; Kerkhoff RM; Pakin SK; Hopewell P; Bansal N
Int J Hyperthermia; 2005 Sep; 21(6):561-74. PubMed ID: 16147440
[TBL] [Abstract][Full Text] [Related]
14. Entrapment of a neutral Tm(III)-based complex with two inner-sphere coordinated water molecules into PEG-stabilized vesicles: towards an alternative strategy to develop high-performance LipoCEST contrast agents for MR imaging.
Chahid B; Vander Elst L; Flament J; Boumezbeur F; Medina C; Port M; Muller RN; Lesieur S
Contrast Media Mol Imaging; 2014; 9(6):391-9. PubMed ID: 24760773
[TBL] [Abstract][Full Text] [Related]
15. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
Caravan P
Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of paramagnetic agents by off-resonance rotating frame technique.
Zhang H; Xie Y
J Magn Reson; 2006 Dec; 183(2):213-27. PubMed ID: 16979920
[TBL] [Abstract][Full Text] [Related]
17. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
Werner EJ; Datta A; Jocher CJ; Raymond KN
Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
[TBL] [Abstract][Full Text] [Related]
18. NMR temperature measurements using a paramagnetic lanthanide complex.
Zuo CS; Metz KR; Sun Y; Sherry AD
J Magn Reson; 1998 Jul; 133(1):53-60. PubMed ID: 9654468
[TBL] [Abstract][Full Text] [Related]
19. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
[TBL] [Abstract][Full Text] [Related]
20. Chiral recognition of Schiff bases by 15N NMR spectroscopy in the presence of a dirhodium complex. Deuterium isotope effect on 15N chemical shift of the optically active Schiff bases and their dirhodium tetracarboxylate adducts.
Rozwadowski Z; Nowak-Wydra B
Magn Reson Chem; 2008 Oct; 46(10):974-8. PubMed ID: 18666208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
